<VariationArchive RecordType="classified" VariationID="599230" VariationName="NM_006996.3(SLC19A2):c.64_70del (p.Thr22fs)" VariationType="Deletion" Accession="VCV000599230" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2019-01-05" MostRecentSubmission="2019-06-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="590455" VariationID="599230">
      <GeneList>
        <Gene Symbol="SLC19A2" FullName="solute carrier family 19 member 2" GeneID="10560" HGNC_ID="HGNC:10938" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169463909" stop="169485970" display_start="169463909" display_stop="169485970" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169433146" stop="169455207" display_start="169433146" display_stop="169455207" Strand="-" />
          </Location>
          <OMIM>603941</OMIM>
        </Gene>
        <Gene Symbol="LOC129931894" FullName="ATAC-STARR-seq lymphoblastoid silent region 1546" GeneID="129931894" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169485589" stop="169485768" display_start="169485589" display_stop="169485768" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_006996.3(SLC19A2):c.64_70del (p.Thr22fs)</Name>
      <CanonicalSPDI>NC_000001.11:169485696:GAGCGGT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169485697" stop="169485703" display_start="169485697" display_stop="169485703" variantLength="7" positionVCF="169485696" referenceAlleleVCF="CGAGCGGT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169454935" stop="169454941" display_start="169454935" display_stop="169454941" variantLength="7" positionVCF="169454934" referenceAlleleVCF="CGAGCGGT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>T22fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.169454935_169454941del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.169454935_169454941del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.169485697_169485703del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.169485697_169485703del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008255.1" sequenceAccession="NG_008255" sequenceVersion="1" change="g.5268_5274del">
            <Expression>NG_008255.1:g.5268_5274del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001319667.1" sequenceAccession="NM_001319667" sequenceVersion="1" change="c.64_70del">
            <Expression>NM_001319667.1:c.64_70del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001306596.1" sequenceAccession="NP_001306596" sequenceVersion="1" change="p.Thr22fs">
            <Expression>NP_001306596.1:p.Thr22fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006996.3" sequenceAccession="NM_006996" sequenceVersion="3" change="c.64_70del" MANESelect="true">
            <Expression>NM_006996.3:c.64_70del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008927.1" sequenceAccession="NP_008927" sequenceVersion="1" change="p.Thr22fs">
            <Expression>NP_008927.1:p.Thr22fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1557894839" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006996.3(SLC19A2):c.64_70del (p.Thr22fs) AND Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness" Accession="RCV000735817" Version="2">
        <ClassifiedConditionList TraitSetID="1649">
          <ClassifiedCondition DB="MedGen" ID="C0342287">Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-03-16" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-03-16" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2019-01-05" MostRecentSubmission="2019-06-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1649" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4256" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness</ElementValue>
                <XRef ID="Thiamine+responsive+megaloblastic+anemia+syndrome/7055" DB="Genetic Alliance" />
                <XRef ID="237617006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA, DIABETES MELLITUS, AND DEAFNESS TYPE)</ElementValue>
                <XRef Type="MIM" ID="249270" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine-responsive anemia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rogers syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine-responsive myelodysplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">THMD1</ElementValue>
                <XRef Type="MIM" ID="249270" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TRMA</ElementValue>
                <XRef Type="MIM" ID="249270" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9210" />
                <XRef ID="9210" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus. Onset of megaloblastic anemia occurs between infancy and adolescence. The anemia is corrected with thiamine treatment, but the red cells remain macrocytic and anemia can recur if treatment is withdrawn. Progressive sensorineural hearing loss often occurs early and can be detected in toddlers; hearing loss is irreversible and may not be prevented by thiamine treatment. The diabetes mellitus is non-type I in nature, with age of onset from infancy to adolescence. Thiamine treatment may reduce insulin requirement and delay onset of diabetes in some individuals.</Attribute>
                <XRef ID="NBK1282" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301459</ID>
                <ID Source="BookShelf">NBK1282</ID>
              </Citation>
              <XRef ID="49827" DB="Orphanet" />
              <XRef ID="C0342287" DB="MedGen" />
              <XRef ID="MONDO:0009575" DB="MONDO" />
              <XRef Type="MIM" ID="249270" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1689623" SubmissionDate="2018-12-20" DateLastUpdated="2019-01-05" DateCreated="2019-01-05">
        <ClinVarSubmissionID localKey="SUB4948347" submittedAssembly="GRCh37" title="SUB4948347" />
        <ClinVarAccession Accession="SCV000863574" DateUpdated="2019-01-05" DateCreated="2019-01-05" Type="SCV" Version="1" SubmitterName="Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital" OrgID="1027" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-03-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A2">
              <Name>solute carrier family 19 member 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006996.2:c.64_70delACCGCTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0342287" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4948347</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1799357" SubmissionDate="2019-02-28" DateLastUpdated="2019-06-03" DateCreated="2019-06-03">
        <ClinVarSubmissionID localKey="NM_006996.2:c.64_70delACCGCTC|MedGen:C0342287" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000920413" DateUpdated="2019-06-03" DateCreated="2019-06-03" Type="SCV" Version="1" SubmitterName="Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital" OrgID="1027" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-03-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006996.2:c.64_70delACCGCTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0342287" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5253510</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1799357" TraitType="Disease" MappingType="Name" MappingValue="Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness" MappingRef="Preferred">
        <MedGen CUI="C0342287" Name="Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1689623" TraitType="Disease" MappingType="Name" MappingValue="Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness" MappingRef="Preferred">
        <MedGen CUI="C0342287" Name="Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

